Document Detail


Nongalenic cerebral arteriovenous malformations in neonates and infants. Review of 26 consecutive cases (1982-1992).
MedLine Citation:
PMID:  7621485     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We present 26 consecutive cases of nongalenic pial arteriovenous malformations (PAVMs) diagnosed in the neonatal period or in infancy. No diagnosis was made antenatally. Presenting symptoms in neonates were systemic cardiac manifestations (54%), seizures (31%), and hemorrhages (15%). In infants, hemorrhagic strokes and hydrodynamic disorders (external or internal hydrocephaly, macrocephaly, atrophy) both occurred in 38% of cases. Systemic cardiac manifestations and seizures were rare at that age (respectively 16% and 8%). Sixty-two percent of neonates and 31% of infants already had neurocognitive disorders (assessed by pediatric neurocognitive testing: Brunet-Leizine and Denver tests) when referred. The venous drainage and its anomalies (ectasias, stenoses, thromboses) were the main causes of symptoms. Atrophy and leukomalacic lesions occurred rapidly; they express local hydrovenous disorders and are specific to this population group. Untreated neonates and infants have a poor prognosis. Endovascular treatment, although partial and challenging in all instances, represents the treatment of choice in our series. Of the eight neonates treated, one improved to normal (12.5%), while four remained stable (50%): two neurologically normal, two with mild neurological deficit. Three (37%) died despite embolization (heart failure, multiorgan failure, postoperative death). Transient neurological complications occurred in two cases (25%): hemiparesis in one patient with a rolandic and in one with a thalamic AVM. Of the eight infants successfully embolized, one was significantly improved (12.5%) and is now neurologically normal, while five remained stable (62.5%): four neurologically normal, one with mild neurological deficit. One died between two sessions of embolization from intracerebral hemorrhage (12.5%). Hemianopsy occurred in one case (12.5%) after embolization of an occipital AVM. In one additional case in a normal child we failed to embolize the last small pial AVM of four after the three others had spontaneously thrombosed. With a minimal follow-up of 18 months and a maximum of 7 years, the review of our series shows 53% of the initial group of neonates and infants growing neurologically normal after therapeutic management in our institution; 23.5% died despite treatment, and the remaining 23.5% present minor neurological deficit. When targeted at the points of angioarchitectural weakness, embolization contributes to stabilizing a lesion. It should be undertaken rapidly to avoid loss of brain substance secondary to hemorrhage, atrophy, or leukomalacia, and to allow neurocognitive recovery and normal brain maturation. In our experience, these lesions are the most aggressive ones for the maturing brain, and the most difficult to approach technically. They represent a new therapeutic field and have their own specific anatomy and physiology.
Authors:
G Rodesch; V Malherbe; H Alvarez; M Zerah; D Devictor; P Lasjaunias
Related Documents :
22399215 - Perinatal arterial ischemic stroke in northern queensland.
783025 - A controlled study of the eeg during transcendental meditation: comparison with hypnosis.
22407135 - More than just a pretty face. the relationship between infant's temperament, food accep...
22825275 - Intact newborn survival after spontaneous umbilical cord vascular rupture before labor.
3109205 - Etiology and diagnosis of neonatal conjunctivitis.
22483615 - Galactosemia: when is it a newborn screening emergency?
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery     Volume:  11     ISSN:  0256-7040     ISO Abbreviation:  Childs Nerv Syst     Publication Date:  1995 Apr 
Date Detail:
Created Date:  1995-08-31     Completed Date:  1995-08-31     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8503227     Medline TA:  Childs Nerv Syst     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  231-41     Citation Subset:  IM    
Affiliation:
Hôpital Bicêtre, Le Kremlin Bicêtre, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Brain Damage, Chronic / diagnosis
Cerebral Angiography
Child
Child, Preschool
Embolization, Therapeutic
Enbucrilate
Female
Follow-Up Studies
Humans
Hydrocephalus / complications,  diagnosis,  therapy
Infant
Infant, Newborn
Intracranial Arteriovenous Malformations / complications,  diagnosis*,  therapy
Magnetic Resonance Imaging
Male
Neurologic Examination
Pia Mater / blood supply
Postoperative Complications / diagnosis
Risk Factors
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
6606-65-1/Enbucrilate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characteristics of cerebrospinal fluid circulation in infants as detected with MR velocity imaging.
Next Document:  Cranial fasciitis with massive intracranial extension.